Campbell & CO Investment Adviser LLC Sells 23,372 Shares of Nu Skin Enterprises, Inc. $NUS

Campbell & CO Investment Adviser LLC trimmed its stake in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) by 47.8% in the 2nd quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 25,516 shares of the company’s stock after selling 23,372 shares during the period. Campbell & CO Investment Adviser LLC’s holdings in Nu Skin Enterprises were worth $204,000 as of its most recent filing with the Securities & Exchange Commission.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in NUS. Prescott Group Capital Management L.L.C. grew its position in Nu Skin Enterprises by 142.7% in the 1st quarter. Prescott Group Capital Management L.L.C. now owns 1,394,608 shares of the company’s stock worth $10,125,000 after purchasing an additional 819,972 shares during the period. Pacer Advisors Inc. purchased a new position in shares of Nu Skin Enterprises in the 1st quarter worth $4,577,000. Charles Schwab Investment Management Inc. grew its holdings in shares of Nu Skin Enterprises by 47.1% in the first quarter. Charles Schwab Investment Management Inc. now owns 1,052,384 shares of the company’s stock worth $7,640,000 after acquiring an additional 336,807 shares during the period. Y Intercept Hong Kong Ltd grew its holdings in shares of Nu Skin Enterprises by 526.3% in the second quarter. Y Intercept Hong Kong Ltd now owns 239,608 shares of the company’s stock worth $1,914,000 after acquiring an additional 201,353 shares during the period. Finally, Nuveen LLC purchased a new stake in Nu Skin Enterprises during the first quarter valued at $1,402,000. Hedge funds and other institutional investors own 82.84% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have issued reports on NUS shares. Wall Street Zen cut Nu Skin Enterprises from a “strong-buy” rating to a “buy” rating in a research report on Saturday. Zacks Research raised shares of Nu Skin Enterprises to a “hold” rating in a report on Tuesday, August 12th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Nu Skin Enterprises in a research report on Wednesday, October 8th. Three investment analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $7.00.

Insider Activity at Nu Skin Enterprises

In other news, Director Daniel W. Campbell sold 23,391 shares of the business’s stock in a transaction dated Friday, August 29th. The stock was sold at an average price of $12.10, for a total value of $283,031.10. Following the transaction, the director directly owned 53,375 shares in the company, valued at $645,837.50. The trade was a 30.47% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Chayce David Clark sold 20,000 shares of the company’s stock in a transaction dated Wednesday, September 3rd. The stock was sold at an average price of $11.97, for a total value of $239,400.00. Following the completion of the transaction, the executive vice president directly owned 233,140 shares of the company’s stock, valued at approximately $2,790,685.80. This trade represents a 7.90% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last quarter, insiders have sold 58,926 shares of company stock worth $711,364. 2.00% of the stock is owned by corporate insiders.

Nu Skin Enterprises Stock Performance

Shares of NUS opened at $9.50 on Wednesday. The business has a 50-day simple moving average of $11.04 and a two-hundred day simple moving average of $9.68. The company has a quick ratio of 1.38, a current ratio of 2.01 and a debt-to-equity ratio of 0.27. Nu Skin Enterprises, Inc. has a 52 week low of $5.32 and a 52 week high of $14.62. The stock has a market cap of $463.27 million, a price-to-earnings ratio of 4.73 and a beta of 0.97.

Nu Skin Enterprises (NYSE:NUS) last announced its quarterly earnings data on Thursday, November 6th. The company reported $0.34 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.30 by $0.04. The company had revenue of $364.21 million during the quarter, compared to the consensus estimate of $374.20 million. Nu Skin Enterprises had a return on equity of 8.23% and a net margin of 6.20%. Nu Skin Enterprises has set its FY 2025 guidance at 1.250-1.350 EPS. Q4 2025 guidance at 0.250-0.350 EPS. On average, analysts expect that Nu Skin Enterprises, Inc. will post 1.05 EPS for the current year.

Nu Skin Enterprises Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 10th. Stockholders of record on Friday, November 28th will be given a dividend of $0.06 per share. This represents a $0.24 annualized dividend and a dividend yield of 2.5%. The ex-dividend date is Friday, November 28th. Nu Skin Enterprises’s dividend payout ratio (DPR) is presently 11.01%.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc, together with its subsidiaries, engages in the development and distribution of various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO; and nutricentials skin care products.